The size and complexity of CENTER-TBI necessitates a strong management structure. This will be implemented by close collaboration between Prof. Andrew Maas (UZA), the Project Coordinator and Prof. David Menon (UCAM) who will act as vice coordinator and co-chairman of the Management Committee. Their work will be supported by a Management Committee which will act as the executive body for the project, and facilitate coordination and integration of activities of all participants. In contrast to other, less complex collaborative projects, the Management Committee will be the decision making body of the consortium. This organisation will promote and efficient and effective management for this complex project. The Management Committee will report on project progress and is accountable to the General Assembly.

Project Coordinator

Prof. Andrew I.R. Maas from the Antwerp University Hospital will be the Project Coordinator of CENTER-TBI. He is the intermediary between the European Commission and the Consortium and as such will be responsible for all scientific activities of the consortium. Supervision of the overall progress of the project will be conducted in close collaboration with Prof. David Menon form the University of Cambridge as co-chairman of the Management Committee.

Management Committee (11 members)

Prof. Andrew I.R. Maas Project Coordinator

BE Antwerp, Belgium

Prof. David K. Menon Co-chairman

UK Cambridge, UK

Prof. Ewout Steyerberg

NL Rotterdam, Netherlands

Prof. Fiona Lecky UK Sheffield, UK

Dr. Giuseppe Citerio IT Monza, Italy

Prof. Geoff Manley US San Fransisco, USA

Dr. Linda Lanyon INCF

SE Stockholm, Sweden

Natasha Perera

Dr. Natascha Perera ARTTIC

DE Munich, Germany

Dr. Valerie Legrand ICON

FR Paris, France

Representatives of the investigators (non-voting members of the MC):

Prof. Nino Stocchetti Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

IT Milan, Italy

Prof. Wilco Peul Leiden University

DE Leiden, Netherlands

Collectively, the members of the Management Committee represent a broad range of multidisciplinary clinical, biostatistical and neuro-informatics expertise. Each member has a vast experience and proven track record in scientific research and/or coordination of international projects and studies.

The General Assembly (GA)

The General Assembly is composed of all involved Participants. Each Participant has one vote.

The General Assembly consists of one representative of each Participant with authority to vote. All other non-voting researchers working for this project may join the meetings and discussions. The General Assembly is the body approving and amending decisions made by the Coordinators and/or the Management Committee. The main tasks of the General Assembly are:

  • Grant proper implementation of the Participants respective rights and obligations in accordance with the contractual framework of the project and the Consortium Agreement
  • Critically review, discuss, approve and/or amend executive decisions taken by the Management Committee
  • Grant proper implementation of the Participants respective rights and obligations in accordance with the contractual framework of the project and the Consortium Agreement
  • Critically review, discuss, approve and/or amend executive decisions taken by the Management Committee
  • Decide upon withdrawal, inclusion and exclusion of Participants to the project
  • Take preliminary decisions on the amendment of the Consortium Agreement (subject to ratification by the authorised legal representatives)
  • Agree on standard operation procedures within CENTER-TBI, in relation to reporting procedures
  • Agree on procedures and policies in accordance with the Grant Agreement, Annex II, Article 30 for dissemination of foreground and IPR
  • Approve the provisional budgets, discuss and approve the annual executive budget and cost claims prepared by the Steering Committee including the reimbursements to the Participants.

CENTER-TBI Participants

The CENTER-TBI project consists of 37 participants and 10 associated participants, who will contribute their expertise and time to the project.
The CENTER-TBI participants will perform the scientific analyses.

.

Scientific Advisory Board (SAB) (10 members)

The Scientific Advisory Board (SAB) forms an important component of CENTER-TBI. The main role of the Advisory Board is to act as a sounding board for the Participants as ideas and results flow from the project. The Advisory Board will also help to maintain an appropriate balance between scientific and patient perspectives in the real world of the clinical management of patients with TBI. We recognize that much collective knowledge and wisdom is available amongst the Participants of CENTER-TBI, but place great value on an external and independent body to guide and support the Coordinators and Participants in this complex project.

The Scientific Advisory Board will consist of methodological and clinical experts as well as representatives of patient organisations. The Scientific Advisory Board will also include a member with ethical expertise who will also assume the role of external independent ethics advisor for the project and regulatory/pharmaceutical expert.

The Scientific Advisory Board will ensure a high standard of research and monitor the progress of the project by taking part in the annual General Assembly meetings and discussing progress and problems directly with the Management Committee. Whenever appropriate, it will consult the consortium and make recommendations as to improve their performance.

Prof. David Hovda Neuroscientist UCLA

USA Los Angeles, US

Prof. Gordon Murray Statistician, Univ. of Edinburgh

UK Edinburgh, UK

Prof. Dik Habbema Em. prof. Medical Decision Making

NL Rotterdam, NL

Prof. Jan Schwab Hannelore Kohl Foundation

DE Berlin, Germany

Joseph Hellerstein Google Inc.

USA Seattle, US

Mary Baker President European Brain Council

BE Brussels, Belgium

Patrick B. Donohue Chairman Sarah Jane Foundation

USA New York, US

Dr. Michael J. Bell Paediatric Expert

USA Pittsburgh, US

Dr Christiane Druml Medical University of Vienna

AT Vienna, Austria

Dr Marie-Noëlle Castel Sanofi-Aventis

FR Paris, France